Compound Evidence File
#EC-2026-0064
Dianabol
Filed under Oral Tablets. The bureau holds 180 laboratory returns for this compound from 67 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
67 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 10.0 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 13 Apr 2026 | 20 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 26 Mar 2026 | 6 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 16 Mar 2026 | 27 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 10.0 | 10.0 | 22 May 2026 | 24 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 19 Feb 2026 | 20 May 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Apr 2026 | 17 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 3 Jun 2026 | 5 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 10.0 | 10.0 | 19 Feb 2026 | 5 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 25 Nov 2025 | 4 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 11 Jun 2026 | 2 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 10.0 | 10.0 | 10.0 | 7 Nov 2025 | 19 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 7 Jan 2026 | 10 Mar 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 10.0 | 10.0 | 10.0 | 11 Feb 2026 | 26 May 2026 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 | 6 May 2025 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 2 May 2026 | 15 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 3 Dec 2025 | 4 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Apr 2026 | 26 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 10.0 | 16 Mar 2026 | 16 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 9.9 | 9.9 | 10.0 | 17 Mar 2026 | 2 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 9.9 | 9.9 | 10.0 | 4 Jul 2026 | 17 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 2 May 2026 | 18 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Jun 2026 | 21 Jul 2026 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 9.6 | 9.6 | 9.6 | 20 Jun 2025 | 20 Jun 2025 |
| Lisa BiopeptideCASE #VI-2026-0131 | X | 1 | 9.5 | 9.5 | 9.5 | 27 Feb 2025 | 27 Feb 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 9.5 | 9.5 | 9.5 | 28 Mar 2025 | 28 Mar 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 9.2 | 8.3 | 9.8 | 23 May 2026 | 23 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 9.0 | 8.2 | 10.0 | 25 May 2026 | 25 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 9.0 | 8.7 | 9.4 | 24 May 2026 | 24 May 2026 |
| Atomik LabzCASE #VI-2026-0327 | X | 2 | 8.6 | 7.3 | 9.8 | 13 Feb 2025 | 25 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 8.5 | 8.0 | 8.9 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.4 | 7.5 | 10.0 | 21 May 2026 | 21 May 2026 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 8.2 | 8.2 | 8.2 | 27 Feb 2025 | 27 Feb 2025 |
| Diju Peptides Wellness and CoCASE #VI-2026-0724 | X | 1 | 8.2 | 8.2 | 8.2 | 7 May 2025 | 7 May 2025 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 8.1 | 8.1 | 8.1 | 27 Feb 2025 | 27 Feb 2025 |
| InjectifyCASE #VI-2026-0387 | X | 2 | 8.0 | 6.4 | 9.6 | 2 Apr 2025 | 21 May 2026 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 7.9 | 7.9 | 7.9 | 11 Jun 2025 | 11 Jun 2025 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 7.9 | 7.9 | 7.9 | 13 Jun 2025 | 13 Jun 2025 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 3 | 7.8 | 6.7 | 8.6 | 11 Jun 2025 | 20 May 2026 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 7.8 | 7.8 | 7.8 | 2 Jul 2025 | 2 Jul 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 10 | 7.7 | 5.8 | 9.1 | 6 May 2025 | 21 May 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 7.7 | 7.7 | 7.7 | 16 Mar 2025 | 16 Mar 2025 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 7.7 | 7.7 | 7.7 | 7 May 2025 | 7 May 2025 |
| Mai PeptideCASE #VI-2026-0769 | X | 4 | 7.5 | 6.1 | 8.7 | 11 Jun 2025 | 23 May 2026 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 5 | 7.4 | 5.6 | 8.6 | 8 Jul 2025 | 24 May 2026 |
| Qingdao Hongshengda TradingCASE #VI-2026-0334 | X | 1 | 7.2 | 7.2 | 7.2 | 2 Apr 2025 | 2 Apr 2025 |
| HK PeptidesCASE #VI-2026-0140 | X | 6 | 7.1 | 4.6 | 9.4 | 3 Jul 2025 | 19 Jan 2026 |
| Xingruida XDRCASE #VI-2026-0898 | X | 5 | 7.1 | 5.8 | 8.2 | 28 Mar 2025 | 21 May 2026 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 7.1 | 7.1 | 7.1 | 2 Jul 2025 | 2 Jul 2025 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 3 | 7.0 | 6.9 | 7.0 | 16 Mar 2025 | 21 May 2026 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 7.0 | 7.0 | 7.0 | 13 Feb 2025 | 13 Feb 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 7.0 | 7.0 | 7.0 | 14 Jan 2025 | 14 Jan 2025 |
| Peptide CraftersCASE #VI-2026-0994 | X | 2 | 6.9 | 6.9 | 6.9 | 24 Apr 2025 | 17 May 2026 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 6.4 | 6.4 | 6.4 | 17 Dec 2024 | 17 Dec 2024 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 6.3 | 6.3 | 6.3 | 8 Jul 2025 | 8 Jul 2025 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 6.2 | 6.2 | 6.2 | 2 Jul 2025 | 2 Jul 2025 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 1 | 6.1 | 6.1 | 6.1 | 16 Mar 2025 | 16 Mar 2025 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 6.1 | 6.1 | 6.1 | 8 Jul 2025 | 8 Jul 2025 |
| Allen Biotechnology Co ABCCASE #VI-2026-0709 | X | 1 | 6.0 | 6.0 | 6.0 | 6 May 2025 | 6 May 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 6.0 | 6.0 | 6.0 | 21 May 2025 | 21 May 2025 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 5.6 | 5.6 | 5.6 | 11 Jun 2025 | 11 Jun 2025 |
| ScienceCASE #VI-2026-0636 | X | 1 | 4.9 | 4.9 | 4.9 | 16 Mar 2025 | 16 Mar 2025 |
| Top PeptideCASE #VI-2026-0721 | X | 2 | 4.8 | 3.8 | 5.7 | 25 Apr 2025 | 24 May 2026 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 4.8 | 4.8 | 4.8 | 25 Apr 2025 | 25 Apr 2025 |
| DeuschemCASE #VI-2026-0004 | X | 1 | 3.6 | 3.6 | 3.6 | 11 Jun 2025 | 11 Jun 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.3 | 0.3 | 0.3 | 13 Jun 2025 | 13 Jun 2025 |
Open any subject to view the batch-level evidence for Dianabol alone.